Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant

BACKGROUND: Endocrine therapy constitutes a central modality in the treatment of oestrogen receptor (ER)-positive advanced breast cancer. PURPOSE: To evaluate the evidence for endocrine treatment in postmenopausal patients with advanced breast cancer focusing on the aromatase inhibitors, letrozole,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kümler, Iben, Knoop, Ann S, Jessing, Christina A R, Ejlertsen, Bent, Nielsen, Dorte L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070302/
https://www.ncbi.nlm.nih.gov/pubmed/27843622
http://dx.doi.org/10.1136/esmoopen-2016-000062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070302/
https://www.ncbi.nlm.nih.gov/pubmed/27843622
http://dx.doi.org/10.1136/esmoopen-2016-000062

Ejemplares similares